Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): According to Wells Fargo, the Copaxone patent litigation decision ends Teva’s earnings risk and makes a path for long-term, sustainable growth. The firm gives and Outperform rating on Teva.
Don’t Miss: NIKE Fourth Quarter Earnings Sneak Peek.
Kennametal Inc. (NYSE:KMT) estimates have been lowered by Wells Fargo because of weak order trends, anticipated U.S. distributions channel destocking, FX, and end market deterioration. The firm gives a Market Perform rating on the stock.
Zillow Inc (NASDAQ:Z): Although Zillow’s shares are rising nearly 45% year to date, Citigroup cites channel checks and comScore site traffic data before claiming it views a remaining positive for shares. Citi maintains a Buy rating and a $46 price target on shares.
Shire plc (NASDAQ:SHPGY) price target has been lowered by Deutsche Bank as a result of the approval of generic Adderall XR by the FDA. Shares are given a Buy rating.
Ansys, Inc. (NASDAQ:ANSS): According to Benchmark, this week’s Exa (EXA) IPO, a competitor of ANSYS (NASDAQ:ANSS), will raise focus on the group as well as validate a positive view on the engineering simulation software sector. The firm predicts a short-term ANSYS trading opportunity and a possible 5% upside. The company is given a Buy rating and a $73 price target.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.